Skip to main content

Table 4 Univariate analysis for breast cancer-specific overall survival

From: Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Prognostic factor P RR 95% CI
Age n.s. - -
Menopausal status n.s. - -
pT stage n.s. - -
Grade 0.0003 4.26 1.96–9.29
Steroid hormone receptor status 0.012 0.32 0.13–0.78
HER2_SCO 0.047 1.60 1.01–2.53
HER2_AMP 0.004 3.78 1.54–9.26
HER2_ALG n.s. - -
HER2_COM 0.004 4.18 1.60–10.90
  1. CI, confidence interval; n.s., not significant; RR, relative risk.